Fundraising Fox
Health Technology Holding (HTH)
Pre-Seed–Series B · 2 people tracked
Find your way into Health Technology Holding (HTH)
Sign up to see every warm intro you have to Health Technology Holding (HTH)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Health Technology Holding (HTH) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Hands-on early-stage life‑science investor and advisor offering deep, science-driven due diligence (PoC, MoA, animal models, KOL/clinician interviews) and access to pharma, corporate partnerships and stakeholder networks.
Team · 2 people
from public directories
What they invest in
from 2 of 3 portfolio companiesDigital Health ×2Biotech ×1Healthtech ×1Medical Devices ×1
HQs:United Kingdom×1
Investments · 3 tracked
founders shown can be your intro path
EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.
BiotechDigital Health
Co-investorsAlbionVCMoonstone Venture CapitalUCL Technology FundXGEN VentureBritish Business Bank
Neurofenix develops neuro-rehabilitation technology and delivers virtual in-home therapy services for people recovering from neurological conditions such as stroke.
Digital HealthHealthtechMedical DevicesLondon, GB
Guillem Buxarrais(CEO)inDimitris Athanasiou(CTO)in
Co-investorsAlbionVCEntrepreneur FirstInHealth VenturesOxford Investment Opportunity Network (OION)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Leuko
Portfolio news
latest coverage across their companiesEpilepsy GTx · eu-startups.com · Dec 10, 2025
Frequently asked questions
- What stage does Health Technology Holding (HTH) invest at?
- Health Technology Holding (HTH) invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is Health Technology Holding (HTH)'s typical check size?
- Health Technology Holding (HTH) typically writes checks of $500K – $1M.
- What sectors does Health Technology Holding (HTH) focus on?
- Health Technology Holding (HTH) focuses on AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- Does Health Technology Holding (HTH) lead rounds?
- Health Technology Holding (HTH) typically participates in rounds rather than leading them.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.